
Jonathan G. Sterrett
Examiner (ID: 12922, Phone: (571)272-6881 , Office: P/3623 )
| Most Active Art Unit | 3623 |
| Art Unit(s) | 3623 |
| Total Applications | 825 |
| Issued Applications | 274 |
| Pending Applications | 34 |
| Abandoned Applications | 517 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8981859
[patent_doc_number] => 08512973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Methods of using engineered ketoreductase polypeptides for the stereoselective reduction of acetophenones'
[patent_app_type] => utility
[patent_app_number] => 13/682600
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 48780
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/682600 | Methods of using engineered ketoreductase polypeptides for the stereoselective reduction of acetophenones | Nov 19, 2012 | Issued |
Array
(
[id] => 8866049
[patent_doc_number] => 20130149752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => '(R)-HYDROXYNITRILE LYASE FROM BRASSICACEAE'
[patent_app_type] => utility
[patent_app_number] => 13/680660
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8297
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680660
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680660 | Method for the synthesis of chiral cyanohydrins via a hydroxynitrile lyase from brassicaceae | Nov 18, 2012 | Issued |
Array
(
[id] => 9041217
[patent_doc_number] => 20130243855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'Modified coagulation factor IX polypeptides and use thereof for treatment'
[patent_app_type] => utility
[patent_app_number] => 13/694290
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82121
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13694290
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/694290 | Modified coagulation factor IX polypeptides and use thereof for treatment | Nov 13, 2012 | Abandoned |
Array
(
[id] => 9589109
[patent_doc_number] => 08778649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Use of acidothermus cellulolyticus xylanase for hydrolyzing lignocellulose'
[patent_app_type] => utility
[patent_app_number] => 13/653328
[patent_app_country] => US
[patent_app_date] => 2012-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 10640
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13653328
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/653328 | Use of acidothermus cellulolyticus xylanase for hydrolyzing lignocellulose | Oct 15, 2012 | Issued |
Array
(
[id] => 11277284
[patent_doc_number] => 09493762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Vector, a transformant and a method to produce a polypeptide having activity to selectively hydrolyze a (R)-tropic acid amide in a racemic mixture'
[patent_app_type] => utility
[patent_app_number] => 14/348528
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6530
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348528
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348528 | Vector, a transformant and a method to produce a polypeptide having activity to selectively hydrolyze a (R)-tropic acid amide in a racemic mixture | Sep 27, 2012 | Issued |
Array
(
[id] => 8767532
[patent_doc_number] => 20130095569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) POLYNUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/625088
[patent_app_country] => US
[patent_app_date] => 2012-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 24548
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13625088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/625088 | Pregnancy-associated plasma protein-A2 (PAPP-A2) polynucleotides | Sep 23, 2012 | Issued |
Array
(
[id] => 9211620
[patent_doc_number] => 20140010797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'Fusion Molecules of Rationally-Designed DNA-Binding Proteins and Effector Domains'
[patent_app_type] => utility
[patent_app_number] => 13/623017
[patent_app_country] => US
[patent_app_date] => 2012-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 48137
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13623017
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/623017 | Fusion Molecules of Rationally-Designed DNA-Binding Proteins and Effector Domains | Sep 18, 2012 | Abandoned |
Array
(
[id] => 9054595
[patent_doc_number] => 20130252310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'NOVEL ALDOLASE AND PRODUCTION PROCESS OF SUBSTITUTED ALPHA-KETO ACIDS'
[patent_app_type] => utility
[patent_app_number] => 13/618272
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18107
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13618272
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/618272 | NOVEL ALDOLASE AND PRODUCTION PROCESS OF SUBSTITUTED ALPHA-KETO ACIDS | Sep 13, 2012 | Abandoned |
Array
(
[id] => 8976022
[patent_doc_number] => 20130209452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'GENE DEFECTS AND MUTANT ALK KINASE IN HUMAN SOLID TUMORS'
[patent_app_type] => utility
[patent_app_number] => 13/618400
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 34281
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13618400
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/618400 | GENE DEFECTS AND MUTANT ALK KINASE IN HUMAN SOLID TUMORS | Sep 13, 2012 | Abandoned |
Array
(
[id] => 8707972
[patent_doc_number] => 20130065261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'MODIFIED GLUCOSE DEHYDROGENASE GENE'
[patent_app_type] => utility
[patent_app_number] => 13/598944
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9168
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13598944
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/598944 | Modified glucose dehydrogenase | Aug 29, 2012 | Issued |
Array
(
[id] => 10967530
[patent_doc_number] => 20140370563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE RELIEF OF INHIBITION OF ALDEHYDE DECARBONYLASE'
[patent_app_type] => utility
[patent_app_number] => 14/240836
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8962
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240836
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240836 | COMPOSITIONS AND METHODS FOR THE RELIEF OF INHIBITION OF ALDEHYDE DECARBONYLASE | Aug 23, 2012 | Abandoned |
Array
(
[id] => 9569163
[patent_doc_number] => 20140186877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE BIOSYNTHESIS OF 1-ALKENES IN ENGINEERED MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 14/240118
[patent_app_country] => US
[patent_app_date] => 2012-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26597
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240118
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240118 | COMPOSITIONS AND METHODS FOR THE BIOSYNTHESIS OF 1-ALKENES IN ENGINEERED MICROORGANISMS | Aug 21, 2012 | Abandoned |
Array
(
[id] => 11773710
[patent_doc_number] => 09382553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Host cells and methods for producing 1-deoxyxylulose 5-phosphate (DXP) and/or a DXP derived compound'
[patent_app_type] => utility
[patent_app_number] => 13/587826
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 10158
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587826
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587826 | Host cells and methods for producing 1-deoxyxylulose 5-phosphate (DXP) and/or a DXP derived compound | Aug 15, 2012 | Issued |
Array
(
[id] => 8522729
[patent_doc_number] => 20120322137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'Cytotoxic Ribonuclease Variants'
[patent_app_type] => utility
[patent_app_number] => 13/559063
[patent_app_country] => US
[patent_app_date] => 2012-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7783
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13559063
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/559063 | Cytotoxic ribonuclease variants | Jul 25, 2012 | Issued |
Array
(
[id] => 8884158
[patent_doc_number] => 20130157342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'NOVEL ALDOLASE AND PRODUCTION PROCESS OF SUBSTITUTED ALPHA-KETO ACIDS'
[patent_app_type] => utility
[patent_app_number] => 13/533317
[patent_app_country] => US
[patent_app_date] => 2012-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18085
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533317
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/533317 | Recombinant polynucleotide, host cells containing the same and a process for producing a protein having aldolase activity | Jun 25, 2012 | Issued |
Array
(
[id] => 8455321
[patent_doc_number] => 20120266266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'METHODS OF PRODUCING GENETICALLY-MODIFIED EUKARYOTIC CELLS WITH RATIONALLY-DESIGNED MEGANUCLEASES'
[patent_app_type] => utility
[patent_app_number] => 13/532190
[patent_app_country] => US
[patent_app_date] => 2012-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26564
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532190
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/532190 | Method for producing genetically-modified cells with rationally-designed meganucleases with altered sequence specificity | Jun 24, 2012 | Issued |
Array
(
[id] => 11845702
[patent_doc_number] => 09733253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay'
[patent_app_type] => utility
[patent_app_number] => 13/529907
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5900
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13529907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/529907 | Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay | Jun 20, 2012 | Issued |
Array
(
[id] => 9537688
[patent_doc_number] => 20140162335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'Recombinant Yeast Expressing AGT1'
[patent_app_type] => utility
[patent_app_number] => 14/127566
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10475
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127566
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127566 | Recombinant Yeast Expressing AGT1 | Jun 20, 2012 | Abandoned |
Array
(
[id] => 10083505
[patent_doc_number] => 09120844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Method for changing conformation of globular proteins'
[patent_app_type] => utility
[patent_app_number] => 13/479294
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4810
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13479294
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/479294 | Method for changing conformation of globular proteins | May 23, 2012 | Issued |
Array
(
[id] => 8489506
[patent_doc_number] => 20120288913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/470104
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17027
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470104
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470104 | NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS | May 10, 2012 | Abandoned |